EphA4 Mediates Pro- and Antitumoral Effects Through Upstream Negative Regulation of AKT in Head and Neck Squamous Cell Carcinoma
Sophia Corbo, Khalid N.M. Abdelazeem, Diemmy Nguyen, Shilpa Bhatia et autres
0 citationsCancer Immunology Research
Enrique Sanz‐García
Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.
157Publications signalées
926Citations signalées
1Affiliations récentes
Institutions déclarées
Domaines associés
Colorectal Cancer Treatments and StudiesCancer Immunotherapy and BiomarkersPancreatic and Hepatic Oncology ResearchCancer Genomics and DiagnosticsIntraperitoneal and Appendiceal Malignancies
Publications récentes
HPV Serology and Circulating Viral DNA for Detection, Genotyping, and Measurement of Disease Burden in Oropharyngeal Cancer
Lucas Penny, Eric Yang Stutheit‐Zhao, Birgitta E. Michels, Fabian Rosing et autres
0 citationsInternational Journal of Cancer
Disease Site‐Specific Outcomes in p 16‐Positive Non‐Oropharyngeal Mucosal Head and Neck Cancer
Revadhi Chelvarajah, Lessandra Y. S. Chee, Jie Su, Brian O'Sullivan et autres
0 citationsHead & Neck
Investigating Early Kinetics in Plasma ctDNA and Peripheral T-cell Receptor Repertoire to Predict Treatment Outcomes to PD-1 Inhibitors in Head and Neck Squamous Cell Carcinoma
Enrique Sanz‐García, Shirin Soleimani, Jeffrey P. Bruce, Stephanie Pedersen et autres
0 citationsClinical Cancer Research
Response to Immune Checkpoint Blockade Is Enhanced in the Presence of Hematopoietic TET2 Inactivation
Vincent Rondeau, Suraj Bansal, Marco M. Buttigieg, Andy G.X. Zeng et autres
6 citationsCancer Research
Nomogram for Risk-Adaptive Estimation of the Locoregional Control Benefit Following Postoperative Radiation Therapy for Pathologic N0 Oral Cavity Cancer: A Retrospective Analysis
Max Gau, Jie Su, Shao Hui Huang, Fatimah A. Alfaraj et autres
1 citationInternational Journal of Radiation Oncology*Biology*Physics
Data from Phase 2 Study of Zilovertamab Vedotin in Participants with Metastatic Solid Tumors
Funda Meric‐Bernstam, Martin Gutierrez, Enrique Sanz‐García, Diego Villa et autres
0 citations
Supplemental Table S5 from Phase 2 Study of Zilovertamab Vedotin in Participants with Metastatic Solid Tumors
Funda Meric‐Bernstam, Martin Gutierrez, Enrique Sanz‐García, Diego Villa et autres
0 citations
Table 4 from Phase 2 Study of Zilovertamab Vedotin in Participants with Metastatic Solid Tumors
Funda Meric‐Bernstam, Martin Gutierrez, Enrique Sanz‐García, Diego Villa et autres
0 citations
Supplemental Table S3 from Phase 2 Study of Zilovertamab Vedotin in Participants with Metastatic Solid Tumors
Funda Meric‐Bernstam, Martin Gutierrez, Enrique Sanz‐García, Diego Villa et autres
0 citations
Supplemental Table S6 from Phase 2 Study of Zilovertamab Vedotin in Participants with Metastatic Solid Tumors
Funda Meric‐Bernstam, Martin Gutierrez, Enrique Sanz‐García, Diego Villa et autres
0 citations
Supplemental Fig S1 from Phase 2 Study of Zilovertamab Vedotin in Participants with Metastatic Solid Tumors
Funda Meric‐Bernstam, Martin Gutierrez, Enrique Sanz‐García, Diego Villa et autres
0 citations
BNTIC News n’est pas le producteur de ces données. Recherche à la demande dans Crossref et Europe PMC, sans clé ; OpenAlex reste optionnel. Aucun service payant requis, aucune réponse conservée. Sources et limites.